Cooley @ SXSW

Connecting innovators
across the Lone Star State

Cooley is proud to help put the “tech” in Texas, supporting our clients’ successes statewide.

Our clients – across the Lone Star State and elsewhere – are the world’s most dynamic companies and investors, disrupting industries and developing breakthrough technologies.

At Cooley, we do business differently. We have to.

The combination of our experience, massively collaborative platform and high volume of work transactions means that we bring a highly tuned and unique understanding of both sides of the deal table, as well as the landscape of current market terms.

Our industry-leading subject matter practitioners are integral members of our client teams, advising on transactions and providing strategic counseling services.

Success for Cooley clients

Significant matters Cooley has advised on include:

• NewLink Genetics, a biopharmaceutical company focused on developing novel immuno-oncology product candidates, on its license and collaboration agreement with Merck
• Lumos Pharma, a biopharmaceutical company that develops treatments for cancer and rare diseases, on its merger with Double Point Ventures
• Castle Biosciences, a commercial-stage dermatological cancer company, on its acquisition of AltheaDx for up to $140 million
• Ambiq Micro, a developer of integrated circuits designed to reduce power consumption in electronic circuits, on its Series D through Series G funding rounds
• CS Disco, an artificial intelligence-driven legal software and services company, on its initial public offering
• Ethos Technologies, a developer of an online insurance platform, on its Series D financing
• ESW Capital, a private equity firm, on its acquisition and take-private of Jive Software, a provider of industry-leading interactive intranet and customer community solutions for $462 million
• Sazerac, one of the world’s largest distilled spirits companies, on its agreement to acquire BuzzBallz, a woman-owned and family-operated distillery, winery and brewery in Texas
• Silverton Partners, a venture capital firm on the formation of its $248 million Fund VII
• Ridge Ventures, an early-stage venture firm on the closing of its $180 million Ridge V Fund